| Literature DB >> 24200831 |
Angela M Caliendo1, David N Gilbert, Christine C Ginocchio, Kimberly E Hanson, Larissa May, Thomas C Quinn, Fred C Tenover, David Alland, Anne J Blaschke, Robert A Bonomo, Karen C Carroll, Mary Jane Ferraro, Lisa R Hirschhorn, W Patrick Joseph, Tobi Karchmer, Ann T MacIntyre, L Barth Reller, Audrey F Jackson.
Abstract
In this IDSA policy paper, we review the current diagnostic landscape, including unmet needs and emerging technologies, and assess the challenges to the development and clinical integration of improved tests. To fulfill the promise of emerging diagnostics, IDSA presents recommendations that address a host of identified barriers. Achieving these goals will require the engagement and coordination of a number of stakeholders, including Congress, funding and regulatory bodies, public health agencies, the diagnostics industry, healthcare systems, professional societies, and individual clinicians.Entities:
Keywords: clinical microbiology; diagnostics; infectious diseases; molecular diagnostics; point-of-care testing; rapid diagnostics
Mesh:
Year: 2013 PMID: 24200831 PMCID: PMC3820169 DOI: 10.1093/cid/cit578
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079